{"retracted":false,"update":{"timestamp":1438819200000,"doi":"10.1007/s00251-015-0861-2","type":"correction"},"doi":"10.1007/s00251-013-0679-8","journal":"Immunogenetics","publisher":"Springer Nature","title":"Erratum to: FCGR3A-158 polymorphism influences the biological response to infliximab in Crohnâ€™s disease through affecting the ADCC activity"}
